Author:
Kumari Anjali,Aggarwal Geeta,Kaur Amanpreet
Publisher
Springer Nature Singapore
Reference56 articles.
1. Rahman, M., Suman, S., & Beg, S. (2017). Pharmaceutical QbD: Omnipresence in the product development lifecycle. European Pharmceutical Review (1).
2. Sharma, N., Singh, S., Behl, T., Gupta, N., Gulia, R., & Kanojia, N. (2022). Explicating the applications of quality by design tools in optimization of microparticles and nanotechnology-based drug delivery systems. Biointerface Research in Applied Chemistry, 12(4), 4317–4336. https://doi.org/10.33263/BRIAC124.43174336
3. Ranjan, D., & Bodla, R. B. (2018). QbD: Key to quality pharmaceuticals. Scholars Academic Journal of Pharmacy. https://doi.org/10.21276/sajp.2018.7.6.8
4. Pharmaceutical CGMPS for the 21 ST century-a risk-based approach final report. 2004.
5. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use pharmaceutical development Q8(R2). 2009.